These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32213911)

  • 1. 2-Oxoester Phospholipase A
    Koutoulogenis GS; Kokotou MG; Hayashi D; Mouchlis VD; Dennis EA; Kokotos G
    Biomolecules; 2020 Mar; 10(3):. PubMed ID: 32213911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2-Oxoesters: A Novel Class of Potent and Selective Inhibitors of Cytosolic Group IVA Phospholipase A
    Kokotou MG; Galiatsatou G; Magrioti V; Koutoulogenis G; Barbayianni E; Limnios D; Mouchlis VD; Satpathy B; Navratil A; Dennis EA; Kokotos G
    Sci Rep; 2017 Aug; 7(1):7025. PubMed ID: 28765606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly Potent 2-Oxoester Inhibitors of Cytosolic Phospholipase A
    Psarra A; Kokotou MG; Galiatsatou G; Mouchlis VD; Dennis EA; Kokotos G
    ACS Omega; 2018 Aug; 3(8):8843-8853. PubMed ID: 30197994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-Oxoamide inhibitors of cytosolic group IVA phospholipase A2 with reduced lipophilicity.
    Antonopoulou G; Magrioti V; Kokotou MG; Nikolaou A; Barbayianni E; Mouchlis VD; Dennis EA; Kokotos G
    Bioorg Med Chem; 2016 Oct; 24(19):4544-4554. PubMed ID: 27522578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction to "Highly Potent 2-Oxoester Inhibitors of Cytosolic Phospholipase A
    Psarra A; Kokotou MG; Galiatsatou G; Mouchlis VD; Dennis EA; Kokotos G
    ACS Omega; 2019 Jun; 4(6):10714. PubMed ID: 31460169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New potent and selective polyfluoroalkyl ketone inhibitors of GVIA calcium-independent phospholipase A2.
    Magrioti V; Nikolaou A; Smyrniotou A; Shah I; Constantinou-Kokotou V; Dennis EA; Kokotos G
    Bioorg Med Chem; 2013 Sep; 21(18):5823-9. PubMed ID: 23916152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-Oxoamide inhibitors of phospholipase A2 activity and cellular arachidonate release based on dipeptides and pseudodipeptides.
    Barbayianni E; Stephens D; Grkovich A; Magrioti V; Hsu YH; Dolatzas P; Kalogiannidis D; Dennis EA; Kokotos G
    Bioorg Med Chem; 2009 Jul; 17(13):4833-43. PubMed ID: 19443224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationship of 2-oxoamide inhibition of group IVA cytosolic phospholipase A2 and group V secreted phospholipase A2.
    Six DA; Barbayianni E; Loukas V; Constantinou-Kokotou V; Hadjipavlou-Litina D; Stephens D; Wong AC; Magrioti V; Moutevelis-Minakakis P; Baker SF; Dennis EA; Kokotos G
    J Med Chem; 2007 Aug; 50(17):4222-35. PubMed ID: 17672443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-Oxoamides based on dipeptides as selective calcium-independent phospholipase A
    Smyrniotou A; Kokotou MG; Mouchlis VD; Barbayianni E; Kokotos G; Dennis EA; Constantinou-Kokotou V
    Bioorg Med Chem; 2017 Feb; 25(3):926-940. PubMed ID: 28034646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationship studies on 1-(2-oxopropyl)indole-5-carboxylic acids acting as inhibitors of cytosolic phospholipase A
    Arnsmann M; Hanekamp W; Elfringhoff AS; Lehr M
    Eur J Med Chem; 2017 Jan; 125():1107-1114. PubMed ID: 27810597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational Exploration of Natural Compounds to Target Cytosolic Phospholipase A 2 Protein: A Novel Therapeutic Target for Spinal Cord Injury.
    Fan H; Wang S; Zhao Q; Qin Z
    Curr Comput Aided Drug Des; 2018; 14(2):117-124. PubMed ID: 29359676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Potent and Selective Inhibitors for Group VIA Calcium-Independent Phospholipase A2 Guided by Molecular Dynamics and Structure-Activity Relationships.
    Mouchlis VD; Limnios D; Kokotou MG; Barbayianni E; Kokotos G; McCammon JA; Dennis EA
    J Med Chem; 2016 May; 59(9):4403-14. PubMed ID: 27087127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β-Lactones: A Novel Class of Ca
    Dedaki C; Kokotou MG; Mouchlis VD; Limnios D; Lei X; Mu CT; Ramanadham S; Magrioti V; Dennis EA; Kokotos G
    J Med Chem; 2019 Mar; 62(6):2916-2927. PubMed ID: 30798607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A New Generation of Arachidonic Acid Analogues as Potential Neurological Agent Targeting Cytosolic Phospholipase A
    Ng CY; Kannan S; Chen YJ; Tan FCK; Ong WY; Go ML; Verma CS; Low CM; Lam Y
    Sci Rep; 2017 Oct; 7(1):13683. PubMed ID: 29057981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of polyfluoro ketones for selective inhibition of human phospholipase A2 enzymes.
    Baskakis C; Magrioti V; Cotton N; Stephens D; Constantinou-Kokotou V; Dennis EA; Kokotos G
    J Med Chem; 2008 Dec; 51(24):8027-37. PubMed ID: 19053783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computer-aided drug design guided by hydrogen/deuterium exchange mass spectrometry: A powerful combination for the development of potent and selective inhibitors of Group VIA calcium-independent phospholipase A
    Mouchlis VD; Morisseau C; Hammock BD; Li S; McCammon JA; Dennis EA
    Bioorg Med Chem; 2016 Oct; 24(20):4801-4811. PubMed ID: 27320659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1-(5-Carboxyindol-1-yl)propan-2-one inhibitors of human cytosolic phospholipase A2α: effect of substituents in position 3 of the indole scaffold on inhibitory potency, metabolic stability, solubility, and bioavailability.
    Bovens S; Schulze Elfringhoff A; Kaptur M; Reinhardt D; Schäfers M; Lehr M
    J Med Chem; 2010 Dec; 53(23):8298-308. PubMed ID: 21067218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of secreted phospholipase A2 suppress the release of PGE2 in renal mesangial cells.
    Vasilakaki S; Barbayianni E; Magrioti V; Pastukhov O; Constantinou-Kokotou V; Huwiler A; Kokotos G
    Bioorg Med Chem; 2016 Jul; 24(13):3029-3034. PubMed ID: 27234891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoliposomal delivery of cytosolic phospholipase A
    Gowda R; Dinavahi SS; Iyer S; Banerjee S; Neves RI; Pameijer CR; Robertson GP
    Nanomedicine; 2018 Apr; 14(3):863-873. PubMed ID: 29317343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interfacial kinetic and binding properties of mammalian group IVB phospholipase A2 (cPLA2beta) and comparison with the other cPLA2 isoforms.
    Ghomashchi F; Naika GS; Bollinger JG; Aloulou A; Lehr M; Leslie CC; Gelb MH
    J Biol Chem; 2010 Nov; 285(46):36100-11. PubMed ID: 20705608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.